SLC5A2 and hydrops fetalis: Angiotensin receptor neprilysin inhibitor and sodium-glucose co-transporter-2 (SGLT2) inhibitors are relatively new medications in use for HF and there is therefore a relative paucity of studies that have looked at the relationship of sarcopenia and use of these medications.